galette pérougienne
Selected indexed studies
- Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical). (J Nucl Med, 2023) [PMID:35835580]
- The role of clinical imaging in oncology drug development: progress and new challenges. (Br J Radiol, 2023) [PMID:37393537]
- [Anaphylactic shock due to French galette. Type I allergic reaction to buckwheat]. (Hautarzt, 2005) [PMID:15205745]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical). (2023) pubmed
- The role of clinical imaging in oncology drug development: progress and new challenges. (2023) pubmed
- [Anaphylactic shock due to French galette. Type I allergic reaction to buckwheat]. (2005) pubmed
- Multiparametric magnetic resonance imaging to characterize cabotegravir long-acting formulation depot kinetics in healthy adult volunteers. (2022) pubmed
- Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical). (2023) pubmed
- Real world experience with [(99m)Tc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry. (2024) pubmed
- Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome. (2021) pubmed
- Discordance Between Serology and Histology for Celiac Disease in a Cohort with Coexisting Liver Disorders. (2020) pubmed
- SNMMI Clinical Trials Network Research Series for Technologists: Imaging Contract Research Organizations, Nuclear Medicine Technologists, and the Role They Play in Medical Imaging Research. (2023) pubmed
- Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study. (2022) pubmed